FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005471134> ?p ?o ?g. }

• W2005471134 endingPage "973" @default.
• W2005471134 startingPage "966" @default.
• W2005471134 abstract "Thrombocytopenia is a substantial clinical problem for patients with myelodysplastic syndromes (MDS). Cytokine treatment for granulocytopenia and anaemia may further reduce the platelet counts. We studied serum thrombopoietin levels (S-TPO) in 52 patients with MDS and 96 healthy controls and related the results to clinical and morphological variables. S-TPO was also assessed after treatment with granulocyte-CSF (G-CSF) and erythropoietin (EPO) in 30 of these patients. S-TPO in MDS was not a normally distributed variable; mean value was 394 pg/ml, SD +/-831 and median value 123 (12-5000 pg/ml). The controls showed lower S-TPO levels than the patients (median 78 pg/ml, P = 0.003) whereas no differences between the MDS subgroups were observed (P = 0.86). Patients with ringed sideroblastic anaemia (RARS) showed the highest platelet counts and higher S-TPO levels than the controls (P = 0.005). No association between platelet counts and S-TPO levels was found in the patients (P = 0.67). TPO levels were generally low in patients with refractory anaemia with an excess of blasts (RAEB), but very high levels were found in five patients. Patients with a high transfusion need had higher S-TPO levels, whereas bone marrow blast counts, cellularity or megakaryocytes showed no correlation with S-TPO. Patients with 5q- showed lower TPO levels than the other patients, indicating that thrombopoietin is not a mediator of thrombocytosis in these cases. Treatment with G-CSF + EPO significantly reduced the platelet counts (P = 0.0002), but this change was not related to significant changes in S-TPO levels or morphology. Patients with RARS and thrombocytosis who normalized their platelet counts showed a concomitant reduction in S-TPO. This may suggest that the increased platelet counts observed in RARS may be caused by increased S-TPO levels. In conclusion, our study shows that platelet, megakaryocyte and thrombopoietin regulation is rather complex in myelodysplastic syndromes and that spontaneous or induced thrombocytopenia are not usually mirrored by increased S-TPO levels." @default.
• W2005471134 created "2016-06-24" @default.
• W2005471134 creator A5031248010 @default.
• W2005471134 creator A5042562663 @default.
• W2005471134 creator A5048370351 @default.
• W2005471134 creator A5049750813 @default.
• W2005471134 date "1999-06-01" @default.
• W2005471134 modified "2023-10-12" @default.
• W2005471134 title "Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology" @default.
• W2005471134 cites W117742811 @default.
• W2005471134 cites W131887615 @default.
• W2005471134 cites W1535968422 @default.
• W2005471134 cites W1541533982 @default.
• W2005471134 cites W187238933 @default.
• W2005471134 cites W1876681729 @default.
• W2005471134 cites W1923887607 @default.
• W2005471134 cites W1973034088 @default.
• W2005471134 cites W1977998150 @default.
• W2005471134 cites W1979820704 @default.
• W2005471134 cites W1982526924 @default.
• W2005471134 cites W1998365820 @default.
• W2005471134 cites W2004089260 @default.
• W2005471134 cites W2006111046 @default.
• W2005471134 cites W2022065694 @default.
• W2005471134 cites W2027250795 @default.
• W2005471134 cites W2028378683 @default.
• W2005471134 cites W2033248764 @default.
• W2005471134 cites W2038023702 @default.
• W2005471134 cites W2040128160 @default.
• W2005471134 cites W2043372417 @default.
• W2005471134 cites W2050219004 @default.
• W2005471134 cites W2056145071 @default.
• W2005471134 cites W2061939324 @default.
• W2005471134 cites W2074558071 @default.
• W2005471134 cites W2079712442 @default.
• W2005471134 cites W2092149157 @default.
• W2005471134 cites W2116774122 @default.
• W2005471134 cites W2147530468 @default.
• W2005471134 cites W2157991084 @default.
• W2005471134 cites W2276322160 @default.
• W2005471134 cites W2300796896 @default.
• W2005471134 cites W29651041 @default.
• W2005471134 cites W4253916874 @default.
• W2005471134 doi "https://doi.org/10.1046/j.1365-2141.1999.01442.x" @default.
• W2005471134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10554808" @default.
• W2005471134 hasPublicationYear "1999" @default.
• W2005471134 type Work @default.
• W2005471134 sameAs 2005471134 @default.
• W2005471134 citedByCount "15" @default.
• W2005471134 countsByYear W20054711342014 @default.
• W2005471134 countsByYear W20054711342016 @default.
• W2005471134 countsByYear W20054711342019 @default.
• W2005471134 countsByYear W20054711342020 @default.
• W2005471134 crossrefType "journal-article" @default.
• W2005471134 hasAuthorship W2005471134A5031248010 @default.
• W2005471134 hasAuthorship W2005471134A5042562663 @default.
• W2005471134 hasAuthorship W2005471134A5048370351 @default.
• W2005471134 hasAuthorship W2005471134A5049750813 @default.
• W2005471134 hasBestOaLocation W20054711341 @default.
• W2005471134 hasConcept C109159458 @default.
• W2005471134 hasConcept C126322002 @default.
• W2005471134 hasConcept C134018914 @default.
• W2005471134 hasConcept C203014093 @default.
• W2005471134 hasConcept C2776694085 @default.
• W2005471134 hasConcept C2777767877 @default.
• W2005471134 hasConcept C2777863708 @default.
• W2005471134 hasConcept C2778248108 @default.
• W2005471134 hasConcept C2778534260 @default.
• W2005471134 hasConcept C2778690821 @default.
• W2005471134 hasConcept C2779788118 @default.
• W2005471134 hasConcept C2780007613 @default.
• W2005471134 hasConcept C2780817109 @default.
• W2005471134 hasConcept C28328180 @default.
• W2005471134 hasConcept C54355233 @default.
• W2005471134 hasConcept C71924100 @default.
• W2005471134 hasConcept C86803240 @default.
• W2005471134 hasConcept C89560881 @default.
• W2005471134 hasConcept C90924648 @default.
• W2005471134 hasConceptScore W2005471134C109159458 @default.
• W2005471134 hasConceptScore W2005471134C126322002 @default.
• W2005471134 hasConceptScore W2005471134C134018914 @default.
• W2005471134 hasConceptScore W2005471134C203014093 @default.
• W2005471134 hasConceptScore W2005471134C2776694085 @default.
• W2005471134 hasConceptScore W2005471134C2777767877 @default.
• W2005471134 hasConceptScore W2005471134C2777863708 @default.
• W2005471134 hasConceptScore W2005471134C2778248108 @default.
• W2005471134 hasConceptScore W2005471134C2778534260 @default.
• W2005471134 hasConceptScore W2005471134C2778690821 @default.
• W2005471134 hasConceptScore W2005471134C2779788118 @default.
• W2005471134 hasConceptScore W2005471134C2780007613 @default.
• W2005471134 hasConceptScore W2005471134C2780817109 @default.
• W2005471134 hasConceptScore W2005471134C28328180 @default.
• W2005471134 hasConceptScore W2005471134C54355233 @default.
• W2005471134 hasConceptScore W2005471134C71924100 @default.
• W2005471134 hasConceptScore W2005471134C86803240 @default.
• W2005471134 hasConceptScore W2005471134C89560881 @default.
• W2005471134 hasConceptScore W2005471134C90924648 @default.
• W2005471134 hasIssue "4" @default.

• next